BridgeBio Pharma Inc vs Western Union Co — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Western Union Co trades at $7.05 (market cap $2.20B). The key difference: BridgeBio Pharma Inc is far larger — about 7.4× Western Union Co's market cap, and Western Union Co pays a 13.33% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | WU | |
|---|---|---|
Market Cap | $16.36B | $2.20B |
Sector | Health | Technology |
52-Week High | $90.17 | $10.28 |
52-Week Low | $47.29 | $6.36 |
Enterprise Value | $18.14B | $2.10B |
Dividend Yield | — | 13.33% |
Trailing returns across standard periods
Latest headlines on both assets
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →